Bloomberg Daybreak: Europe Edition Daybreak Weekend: Pfizer Deal, Nobel Peace, Golden Week
Oct 3, 2025
The discussion dives into how new tariffs on lumber and timber could significantly impact U.S. housing costs. There's a spotlight on Pfizer's recent deal with the White House and its implications for drug pricing. Upcoming Nobel Prize decisions stir political intrigue, with predictions about potential winners and the processes behind nominations. In Asia, insights on Golden Week hint at its effects on consumer spending, while concerns about Hong Kong's real estate landscape reveal challenges for wealthy families.
AI Snips
Chapters
Transcript
Episode notes
Watch Smaller Builders For Early Slowdown Signals
- Expect smaller private builders to delay or cancel projects when faced with tariff uncertainty.
- Monitor builder planning and production as indicators of near-term housing supply changes.
Pfizer Deal Could Be A Template For Pharma
- Pfizer negotiated a three-year tariff reprieve by promising discounted pricing for some drugs and Medicaid price reductions.
- That deal may set a template as other drugmakers seek similar reprieves amid tariff threats and national-security probes.
Direct Sales Work Best For Underinsured Drugs
- TrumpRx aims to let manufacturers sell discounted drugs directly online, but many discounted drugs are already covered by insurance.
- Cash-pay models work better for high-cost, underinsured drugs than for commonly insured medicines.